SLC35C1
GDP-fucose transporter 1
Also known as: FLJ11320, FUCT1, FUCT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96A29
- Gene
- SLC35C1
- Ensembl
- ENSG00000181830
- Chromosome
- 11
- Canonical length
- 364 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
This gene encodes a GDP-fucose transporter that is found in the Golgi apparatus. Mutations in this gene result in congenital disorder of glycosylation type IIc. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]
Canonical amino-acid sequenceUniProt
364 residues, UniProt reviewed canonical sequence.
>Q96A29|SLC35C1
1 MNRAPLKRSR ILHMALTGAS DPSAEAEANG EKPFLLRALQ IALVVSLYWV TSISMVFLNK
61 YLLDSPSLRL DTPIFVTFYQ CLVTTLLCKG LSALAACCPG AVDFPSLRLD LRVARSVLPL
121 SVVFIGMITF NNLCLKYVGV AFYNVGRSLT TVFNVLLSYL LLKQTTSFYA LLTCGIIIGG
181 FWLGVDQEGA EGTLSWLGTV FGVLASLCVS LNAIYTTKVL PAVDGSIWRL TFYNNVNACI
241 LFLPLLLLLG ELQALRDFAQ LGSAHFWGMM TLGGLFGFAI GYVTGLQIKF TSPLTHNVSG
301 TAKACAQTVL AVLYYEETKS FLWWTSNMMV LGGSSAYTWV RGWEMKKTPE EPSPKDSEKS
361 AMGVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC35C1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 92 nTPM
Expression across tissuesHPA
Tissue
- liver: 92 nTPM
- esophagus: 45 nTPM
- salivary gland: 29 nTPM
- adipose tissue: 29 nTPM
- duodenum: 23 nTPM
- small intestine: 23 nTPM
Single-cell type
- esophageal apical cells: 294 nCPM
- breast lactating cells: 69 nCPM
- enterocytes: 60 nCPM
- esophageal suprabasal cells: 55 nCPM
- goblet cells: 44 nCPM
- colonocytes: 44 nCPM
Immune cell
- memory CD4 T-cell: 18 nTPM
- memory CD8 T-cell: 15 nTPM
- T-reg: 13 nTPM
- eosinophil: 13 nTPM
- MAIT T-cell: 13 nTPM
- intermediate monocyte: 12 nTPM
Brain region
- thalamus: 17 nTPM
- medulla oblongata: 15 nTPM
- midbrain: 15 nTPM
- pons: 15 nTPM
- cerebral cortex: 15 nTPM
- hypothalamus: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC35C1.
Disease | AllUniProt
Conditions SLC35C1 is implicated in, by any mechanism.
- Congenital disorder of glycosylation 2C (CDG2C) MIM:266265
Disease | GeneticClinVar
10 pathogenic / likely-pathogenic of 346 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Leukocyte adhesion deficiency type II
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 1.16
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 'de novo' GDP-L-fucose biosynthetic process
- GDP-L-fucose biosynthetic process
- GDP-L-fucose salvage
- negative regulation of Notch signaling pathway
- GDP-fucose import into Golgi lumen
Molecular functions
- antiporter activity
- GDP-fucose transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC35C1 as an antibody target. Whether an autoantibody or antibody against SLC35C1 could matter depends on whether native SLC35C1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC35C1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC35C1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...